Shoji S, Watanabe S, Takamura K, Umezu H, et al. First-line osimertinib treatment in patients with lung squamous cell carcinoma harboring active epidermal growth factor receptor mutations. Lung Cancer 2020;140:113-115.
PMID: 31810534